The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression
Open accessAbstract
It is known from a variety of experimental systems that the ability of tumor cells to grow locally and metastasize can be affected by the presence of adjacent normal tissues and cells, particularly mesenchymally derived stromal cells such as fibroblasts. However, the comparative influence of such normal cell-tumor cell interactions on tumor behavior has not been thoroughly investigated from the perspective of different stages of tumor progression. To address this question we assessed the influence of normal dermal fibroblasts on the growth of human melanoma cells obtained from different stages of tumor progression. We found that the in vitro growth of most (4 out of 5) melanoma cell lines derived from early-stage radial growth phase or vertical growth phase metastatically incompetent primary lesions is repressed by coculture with normal dermal fibroblasts, suggesting that negative homeostatic growth controls are still operative on melanoma cells from early stages of disease. On the other hand, 9 out of 11 melanoma cell lines derived from advanced metastatically competent vertical growth phase primary lesions, or from distant metastases, were found to be consistently stimulated to grow in the presence of dermal fibroblasts. Evidence was obtained to show that this discriminatory fibroblastic influence is mediated by soluble inhibitory and stimulatory growth factor(s). Taken together, these results indicate that fibroblast-derived signals can have antithetical growth effects on metastatic versus metastatically incompetent tumor subpopulations. This resultant conversion in responsiveness to host tissue environmental factors may confer upon small numbers of metastatically competent cells a growth advantage, allowing them to escape local growth constraints both in the primary tumor site and at distant ectopic tissue sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Garin‐Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 749
The Sequential Analysis of Cancer Development
Farber, E., & Cameron, R. (1980) · Advances in cancer research · doi:10.1016/s0065-230x(08)60658-2 · Cited by 594
Antitumor effects of interferon
Gresser, I., & Tovey, M. G. (1978) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(78)90009-4 · Cited by 339
Stromal-epithelial interactions in adult organs
Cunha, G. R., Bigsby, R. M., Cooke, P. S., & Sugimura, Y. (1985) · Cell Differentiation · doi:10.1016/0045-6039(85)90481-6 · Cited by 309
Swope, V. B., ABDEL‐MALEK, Z. A., Kassem, L. M., & Nordlund, J. J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460991 · Cited by 269
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Dotto, G. P., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 201
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
Kerbel, R. S. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60469-8 · Cited by 178
Whicher, J. T., & Evans, S. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.7.1269 · Cited by 175
Rodeck, U., Herlyn, M., Menssen, H. D., Furlanetto, R. W., & Koprowski, H. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400520 · Cited by 143
Cited by
Sorted by citations
Items 201–217 of 217
Fibroblast enhancement of tumor invasion in a tumor-host interface recapitulated in-vitro
Gatenby, R. A., Seftor, E. A., & Hendrix, M. J. C. (1996) · Pathology & Oncology Research · doi:10.1007/bf02903518 · Cited by 1
PERRIN, P., Ringeard, S., Harb, J., Méflah, K., & Ménanteau, J. (1992) · Cell Biology International Reports · doi:10.1016/s0309-1651(06)80040-8 · Cited by 1
Walmsley, G. G., Hu, M. S.-M., Maan, Z. N., Rinkevich, Y., Weissman, I. L., & Longaker, M. T. (2015) · Melanoma Management · doi:10.2217/mmt.15.23 · Cited by 1
IL-2 REGULATION OF IL-24 EXPRESSION LEADS TO GROWTH SUPPRESSION OF MELANOMA CELLS
Jen, E. Y. (2010) · Digital Commons-TMC (Texas Medical Center)
Wang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1
In Vitro Characterisation of Melanoma Progression in a Melanoma Skin Equivalent Model
Haridas, P. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.118574
The pathogenesis of cancer metastasis: relevance to biotherapy
Radinsky, R., Aukerman, S. L., & Fidler, I. J. (2003) · Springer eBooks · doi:10.1007/978-94-017-2757-0_2
Elwakeel, E., Brüggemann, M., Wagih, J., Lityagina, O., Elewa, M. A. F., Han, Y., Frömel, T., Popp, R., Nicolas, A. M., Schreiber, Y., et al. (2023) · doi:10.1158/0008-5472.c.6513943.v1
The Biology of Liver Metastasis
Radinsky, R., & Fidler, I. J. (1998) · Springer eBooks · doi:10.1007/978-1-4471-1506-9_3
Loria, R., Laquintana, V., Scalera, S., Fraioli, R., Caprara, V., Falcone, I., Bazzichetto, C., Martile, M. D., Rosanò, L., Bufalo, D. D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19619337
Immuno-modulatory functions of tenascin-C in a tumor progression model
Murdamoothoo, D. (2018) · theses.fr (ABES) · doi:10.70675/0ebddce2z280az4c92z9177z76ee60326851
Nakipoğlu, M., Mahmoodi, M., Apu, E. H., Shahabipour, F., Di̇ltemi̇z, S. E., Saha, S., Alem, H., & Ashammakhi, N. A. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71734
Metadata
- Authors
- Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., & Kerbel, R. S.
- Affiliations
- Mount Sinai Hospital (CA)
- ORCID
- Theodorescu, D
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-07-15
- Volume
- 88
- Issue
- 14
- Pages
- 6028-6032
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52015
- OpenAlex
- W2015028428
- Cited by
- 217
- References
- 28
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 2 · 2013: 5 · 2012: 5
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health (5r01ca044877-08)
- U.S. Public Health Service (R0I-42331)
- National Cancer Institute (CA-25874, P01CA025874, CA 44877)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- melanoma, dermal fibroblasts, tumor microenvironment, tumor progression, tumor growth, metastasis, radial growth phase, vertical growth phase, tumor stroma, soluble growth factors, metastatic competence
- MeSH terms
- Adipose Tissue, Animals, Cattle, Cell Communication, Cell Division, Cells, Cultured, DNA Replication, Endothelium, Vascular, Fibroblasts, Humans, Infant, Newborn, Male, Melanoma, Skin, Skin Physiological Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
